Nagai S - Search Results

1

Review of primary unknown cancer: cases referred to the National Cancer Center Hospital East.

Matsubara N, Mukai H, Nagai S, Itoh K. Matsubara N, et al. Among authors: nagai s. Int J Clin Oncol. 2010 Dec;15(6):578-82. doi: 10.1007/s10147-010-0112-3. Epub 2010 Aug 11. Int J Clin Oncol. 2010. PMID: 20700615

2

Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer.

Ishihara M, Mukai H, Nagai S, Mukohara T. Ishihara M, et al. Among authors: nagai s. Int J Clin Oncol. 2009 Oct;14(5):431-5. doi: 10.1007/s10147-009-0898-z. Epub 2009 Oct 25. Int J Clin Oncol. 2009. PMID: 19856052

3

Elderly breast cancer therapy: a Japanese experience.

Naito Y, Mukai H, Nagai S. Naito Y, et al. Among authors: nagai s. Jpn J Clin Oncol. 2010 Aug;40(8):717-21. doi: 10.1093/jjco/hyq061. Epub 2010 Apr 29. Jpn J Clin Oncol. 2010. PMID: 20430776

4

Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases.

Matsubara N, Itoh K, Mukai H, Nagai S. Matsubara N, et al. Among authors: nagai s. Int J Clin Oncol. 2012 Oct;17(5):470-6. doi: 10.1007/s10147-011-0312-5. Epub 2011 Oct 7. Int J Clin Oncol. 2012. PMID: 21979749

5

Prognostic impact of Ki-67 overexpression in subgroups categorized according to St. Gallen with early stage breast cancer.

Matsubara N, Mukai H, Itoh K, Nagai S. Matsubara N, et al. Among authors: nagai s. Oncology. 2011;81(5-6):345-52. doi: 10.1159/000334920. Epub 2012 Jan 13. Oncology. 2011. PMID: 22248824

6

Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival.

Ishihara M, Mukai H, Nagai S, Onozawa M, Nihei K, Shimada T, Wada N. Ishihara M, et al. Among authors: nagai s. Oncology. 2013;84(3):135-40. doi: 10.1159/000345321. Epub 2012 Dec 11. Oncology. 2013. PMID: 23235554

7

Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers: a phase I study in Japanese patients.

Mukohara T, Nakajima H, Mukai H, Nagai S, Itoh K, Umeyama Y, Hashimoto J, Minami H. Mukohara T, et al. Among authors: nagai s. Cancer Sci. 2010 Apr;101(4):963-8. doi: 10.1111/j.1349-7006.2009.01465.x. Epub 2009 Dec 9. Cancer Sci. 2010. PMID: 20180805 Free PMC article. Clinical Trial.

8

Eribulin mesylate in patients with refractory cancers: a Phase I study.

Mukohara T, Nagai S, Mukai H, Namiki M, Minami H. Mukohara T, et al. Among authors: nagai s. Invest New Drugs. 2012 Oct;30(5):1926-33. doi: 10.1007/s10637-011-9741-2. Epub 2011 Sep 2. Invest New Drugs. 2012. PMID: 21887501 Free PMC article. Clinical Trial.

9

Moderate renal dysfunction may not require a cisplatin dose reduction: a retrospective study of cancer patients with renal impairment.

Ogawa T, Niho S, Nagai S, Kojima T, Nishimura Y, Ohe Y, Kondo N, Yamaguchi T, Endo K, Izumi K, Minami H. Ogawa T, et al. Among authors: nagai s. Int J Clin Oncol. 2013 Dec;18(6):977-82. doi: 10.1007/s10147-012-0481-x. Epub 2012 Oct 5. Int J Clin Oncol. 2013. PMID: 23053402

10

Recurrence pattern and prognosis of pancreatic cancer after pancreatic fistula.

Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki A, Hayashi M, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakao A. Nagai S, et al. Ann Surg Oncol. 2011 Aug;18(8):2329-37. doi: 10.1245/s10434-011-1604-8. Epub 2011 Feb 16. Ann Surg Oncol. 2011. PMID: 21327822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,458 results

Search Page

Filters